Resilience Therapeutics, Inc. — Form D

Resilience Therapeutics, Inc. of DUXBURY, MA, a company, filed a Form D exempt-offering notice with the SEC on 2016-03-03. The offering totals $10.0M, of which $500K was reported sold. Industry: Pharmaceuticals.

Offering

Filed: 2016-03-03
Form: D
Accession: 0001630938-16-000005
Industry: Pharmaceuticals
Exemptions: 06b
Total offering: $10.0M
Amount sold: $500K
Remaining: $9.5M
Investors: 1
Date of first sale: 2016-02-24
Security types: debt
Revenue range: Decline to Disclose
SEC file number: 021-258548

Issuer

Name: Resilience Therapeutics, Inc.
CIK: 0001630938
Entity type: Corporation
Jurisdiction: DELAWARE
Incorporated: 2014
Address: 536 BAY ROAD, DUXBURY, MA, 02332
Phone: 617-780-2375

Officers, directors & promoters (6)

Name	Role	Location
William M Cowan	Director	DUXBURY, MA
Jason E Fuller	Director	DUXBURY, MA
Jeffrey R Sabados	Director	DUXBURY, MA
Jeffrey R Sabados	Executive Officer	DUXBURY, MA
Retsina M Meyer	Executive Officer	Duxbury, MA
Restina M Meyer	Executive Officer	Duxbury, MA

Other filings by this issuer (4)

Filed	Form	Offering	Sold
2015-07-30	D/A	$3.0M	$2.9M
2015-06-30	D/A	$3.0M	$2.7M
2015-03-09	D/A	$3.0M	$1.3M
2015-01-21	D	$3.0M	$925K

More